PRS16 - The Budget Impact Of Duoresp® Spiromax® Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Italy: Estimated Impact Of Inhalation Technique
Autor: | Torvinen, S, Nicolai, J, Pulimeno, S, di Nola, L, Bruno, GM, Colombo, GL, Di Matteo, S, Valentino, MC, Lewis, A, Blackney, M, Burgio, L, Plich, A |
---|---|
Zdroj: | In Value in Health November 2015 18(7):A496-A496 |
Databáze: | ScienceDirect |
Externí odkaz: |